Application no. and date | 06730774.4 (espacenet) (Federated) (European Patent Register), 20060331 | Patent/reg. no. and date | DK/EP 1864666, 20120815 | Publication date | 20071212 | Priority no. and date | JP 2005100348, 20050331 | EP pub. no. and date |
EP 1864666 20071212 | Effective date | | Applicant/owner | SANTEN PHARMACEUTICAL CO., LTD., 9-19, Shimoshinjo 3-chome
Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651, JP, AGC Inc., 5-1, Marunouchi 1-chome
Chiyoda-ku
Tokyo 100-8405, JP | Applicant ref. no. | P010085EPDK1 | Inventor | ISHIDA, Naruhiro, SANTEN PHARMACEUTICAL CO., LTD, 8916-16, Takayama-cho
Ikoma-shi, Nara, 630-0101, JP, SHIMAZAKI, Atsushi, SANTEN PHARMACEUTICAL CO., LTD, 8916-16, Takayama-cho
Ikoma-shi, Nara, 630-0101, JP | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/5575 (2006.01) , A61P 25/00 (2006.01) , A61P 27/02 (2006.01) | Title | Beskyttelsesmiddel til en retinal neuronal celle indeholdende prostaglandin-F2-alfa-derivat som aktiv ingrediens | Int. application no. | JP2006306826 | Int. publication no. | WO2006106915 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|